Medtronic, a global leader in healthcare technology, today announced the launch of its Adaptive Deep Brain Stimulation (aDBS) ...

Global health-tech major Medtronic has launched its Adaptive Deep Brain Stimulation (aDBS) system in India to improve the ...

Medtronic (NYSE:MDT) announced today that it launched its adaptive deep brain stimulation (aDBS) system in India.

CorTec GmbH today announced that the U.S. Food and Drug Administration (FDA) has accepted the company into its Total Product Life Cycle Advisory Program (TAP), recognizing the Brain Interchange™ BCI ...

The aDBS system uses BrainSense technology, which has been approved by the U.S. Food and Drug Administration (FDA) ...

De Novo FDA submission for moderate-to-severe insomniaHOUSTON, TX, April 22, 2026 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc ...

Nexalin Technology, Inc. (Nasdaq: NXL) (the "Company" or "Nexalin"), the leader in non-invasive Deep Intracranial Frequency Stimulation (DIFS) of the brain ...

BrainsWay shows strong growth in TMS and new indications, but high costs, psychedelic competition & stretched valuation raise ...

Medtronic launches Adaptive DBS in India, offering real‑time Parkinson’s therapy with BrainSense™ to improve patient quality ...

Future treatment approaches for Parkinson’s disease, including gene therapy, stem cell applications and next-generation ...

That’s exactly what happens when you stumble upon Japan House at the University of Illinois at Urbana-Champaign, a slice of authentic Japanese culture hiding in plain sight in the middle of the ...

A Miami woman with Parkinson's disease is regaining control of her hands and daily life after undergoing deep brain ...